Bank of America
MRVI icon

Bank of America’s Maravai LifeSciences MRVI Stock Holding History

Bank of America’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.65M Sell
582,211
-119,503
-17% -$405K ﹤0.01% 4236
2025
Q4 		$2.28M Sell
701,714
-730,650
-51% -$2.46M ﹤0.01% 3963
2025
Q3 		$4.11M Buy
1,432,364
+402,719
+39% +$1.03M ﹤0.01% 4198
2025
Q2 		$2.48M Buy
1,029,645
+151,205
+17% +$318K ﹤0.01% 4583
2025
Q1 		$1.94M Buy
878,440
+189,258
+27% +$748K ﹤0.01% 4708
2024
Q4 		$3.76M Sell
689,182
-205,292
-23% -$1.32M ﹤0.01% 3854
2024
Q3 		$7.43M Sell
894,474
-139,560
-13% -$1.21M ﹤0.01% 3366
2024
Q2 		$7.4M Sell
1,034,034
-259,974
-20% -$2.24M ﹤0.01% 3247
2024
Q1 		$11.2M Buy
1,294,008
+753,702
+139% +$5.1M ﹤0.01% 2883
2023
Q4 		$3.54M Sell
540,306
-654,087
-55% -$4.23M ﹤0.01% 3849
2023
Q3 		$11.9M Buy
1,194,393
+57,297
+5% +$629K ﹤0.01% 2565
2023
Q2 		$14.1M Buy
1,137,096
+670,007
+143% +$9.04M ﹤0.01% 2356
2023
Q1 		$6.54M Buy
467,089
+287,434
+160% +$4.13M ﹤0.01% 3257
2022
Q4 		$2.57M Buy
179,655
+76,126
+74% +$1.2M ﹤0.01% 4029
2022
Q3 		$2.64M Sell
103,529
-109,902
-51% -$2.76M ﹤0.01% 4031
2022
Q2 		$6.06M Sell
213,431
-189,148
-47% -$5.99M ﹤0.01% 3182
2022
Q1 		$14.2M Sell
402,579
-41,973
-9% -$1.41M ﹤0.01% 2505
2021
Q4 		$18.6M Sell
444,552
-25,455
-5% -$1.03M ﹤0.01% 2285
2021
Q3 		$23.1M Buy
470,007
+34,792
+8% +$1.7M ﹤0.01% 2048
2021
Q2 		$18.2M Buy
435,215
+374,687
+619% +$14.5M ﹤0.01% 2234
2021
Q1 		$2.16M Sell
60,528
-32,885
-35% -$1.09M ﹤0.01% 4194
2020
Q4 		$2.62M Buy
+93,413
New +$2.6M ﹤0.01% 3711

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's MRVI Position: Q1 2026 in Review

Bank of America reduced its Maravai LifeSciences (MRVI) stake by 17% in Q1 2026, selling an estimated $405K and leaving 582,211 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #4236.

Bank of America first reported a position in MRVI in Q4 2020 and has held it in 22 quarters since. The position peaked at $23.1M in Q3 2021. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Bank of America held 582,211 shares of Maravai LifeSciences worth $1.65M as of Q1 2026.
  • Bank of America sold 119,503 Maravai LifeSciences shares in Q1 2026, an estimated $405K.
  • Maravai LifeSciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4236 holding.
  • Bank of America first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 22 quarters since.
  • Bank of America's Maravai LifeSciences position peaked at $23.1M in Q3 2021.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.